cdmo.directory
← Compare landing

PharmaBlock vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/pharmablock/sinopep

CategoryPharmaBlockSinopep-Allsino Biopharmaceutical Co., Ltd.
Listed sitecdmocdmo
SummaryLeading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Oral Solid Dosage Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Small Molecule Development & Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
  • Peptide
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Nanjing, Jiangsu, China
  • West Chester, West Chester, PA, USA
  • Hatfield, Hatfield, PA, USA
  • Sunnyvale, Sunnyvale, CA, USA
  • Dezhou, Dezhou, Shandong, China
  • Shaoxing, Shaoxing, Zhejiang, China
  • Tianjin, Tianjin, Tianjin, China
  • Zurich, Zurich, Zurich, Switzerland
  • Horgen, Horgen, Zurich, Switzerland
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.